The third post in life science innovation in the laboratory has been published on Benchfly. In this final post in the guest blogger series by BioBM Principal Consultant Carlton Hoyt he discusses some considerations regarding intellectual property and options for commercializing and realizing revenues from a life science invention. You can read the post on Benchfly here.
The first post, encouraging and discussing ways for life science inventors to act on their ideas, can also be read on the Benchfly blog. The second post, on ballparking the value or revenue potential of an idea, can also be read on Benchfly.
